Clover Health Investments, Corp. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2025: -2.62%

Clover Health Investments, Corp. EBIT Margin is -2.62% for the Trailing 12 Months (TTM) ending June 30, 2025, a -66.63% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Clover Health Investments, Corp. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2024 was -7.85%, a -29.18% change year over year.
  • Clover Health Investments, Corp. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2023 was -11.08%, a -28.49% change year over year.
  • Clover Health Investments, Corp. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2022 was -15.50%, a -66.09% change year over year.
  • Clover Health Investments, Corp. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2021 was -45.70%.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin